Propofol is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Civica, Inc. The primary component is Propofol.
| Product ID | 72572-601_660b7591-24c3-4a9a-9f59-00489db3cee8 | 
| NDC | 72572-601 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Propofol | 
| Generic Name | Propofol | 
| Dosage Form | Injection, Emulsion | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2021-07-16 | 
| Marketing Category | ANDA / | 
| Application Number | ANDA205576 | 
| Labeler Name | Civica, Inc | 
| Substance Name | PROPOFOL | 
| Active Ingredient Strength | 10 mg/mL | 
| Pharm Classes | General Anesthesia [PE],General Anesthetic [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2021-07-16 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0069-0209 | Propofol | Propofol | 
| 0069-0234 | Propofol | Propofol | 
| 0069-0248 | Propofol | Propofol | 
| 0404-9943 | PROPOFOL | propofol | 
| 0409-4699 | PROPOFOL | PROPOFOL | 
| 0409-6010 | PROPOFOL | PROPOFOL | 
| 0591-2136 | Propofol | Propofol | 
| 0641-6194 | Propofol | Propofol | 
| 0641-6195 | Propofol | Propofol | 
| 0641-6196 | Propofol | Propofol | 
| 16714-528 | propofol | propofol | 
| 16714-690 | propofol | propofol | 
| 16714-977 | propofol | propofol | 
| 23155-345 | propofol | propofol | 
| 25021-608 | propofol | propofol | 
| 50090-4569 | Propofol | Propofol | 
| 51662-1293 | PROPOFOL | PROPOFOL | 
| 51662-1470 | PROPOFOL | PROPOFOL | 
| 51662-1471 | PROPOFOL | PROPOFOL | 
| 52584-054 | Propofol | Propofol | 
| 52584-098 | PROPOFOL | propofol | 
| 52584-699 | Propofol | Propofol | 
| 18124-027 | Fresenius Propoven 2% | PROPOFOL | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() PROPOFOL  90235915  not registered Live/Pending  | 
        Twilight Co.  2020-10-05  | 
![]() PROPOFOL  87725806  5534295 Live/Registered  | 
        Liu Xiaojiao  2017-12-19  |